Psychometric validation of the experience with allergic rhinitis nasal spray questionnaire

• Published in: Patient related outcome measures 2011-07, Vol.2 (default), p.127-133
• Main Authors: Crawford, Bruce, Stanford, Richard H, Wong, Audrey Y, Dalal, Anand A, Bayliss, Martha S
• Format: Article
• Language: English
• Subjects: Histamine; Nose; Original Research; Patient compliance; Preferences; Quantitative psychology; Questionnaires; Rhinitis
• ISSN: 1179-271X; 1179-271X
• DOI: 10.2147/PROM.S19371

Patient experience and preference are critical factors influencing compliance in patients with allergic rhinitis (AR) receiving intranasal corticosteroids. The Experience with Allergic Rhinitis Nasal Spray Questionnaire (EARNS-Q) was developed to measure subject experiences with and preferences for nasal sprays. To describe the psychometric validation of the EARNS-Q modules. An observational study was conducted with subjects aged 18-65 years with physician-diagnosed vasomotor, seasonal, and/or perennial allergic rhinitis who were using a prescription nasal spray. Subjects completed the experience module of the EARNS-Q and the Treatment Satisfaction Questionnaire with Medication (TSQM) at baseline and after 2 weeks. Further validation analyses were conducted in a 3-week, randomized, single-blind, crossover, multicenter clinical study in which subjects ≥18 years of age with documented seasonal AR received flunisolide and beclomethasone and completed the EARNS-Q experience module on days 1 and 8, the EARNS-Q preference module on day 22, and the TSQM on days 8 and 22. The observational and clinical studies were completed by 121 and 89 subjects, respectively. Both modules demonstrated acceptable reliability (α = 0.72 experience module; α = 0.93 preference module global scores) and validity (intraclass correlation coefficient or ICC 0.64 to 0.82 test-retest validity). Correlations among the experience and preference modules were moderate (r = 0.39 to 0.79) and within internal consistency reliability estimates, indicating measurement of distinct constructs. The EARNS-Q is a patient-reported outcomes measure that enables reliable and valid measurement of subject experience with, and preference for, prescription intranasal corticosteroid sprays for allergic rhinitis.